MedPath

PAP Adherence After Diet/Lifestyle Intervention in OSA Patients

Not Applicable
Completed
Conditions
Obstructive Sleep Apnea
Interventions
Behavioral: MDG intervention
Registration Number
NCT05881824
Lead Sponsor
University of Crete
Brief Summary

The aim of this study is to explore the role of diet/lifestyle intervention on Positive airway pressure (PAP) treatment adherence in patients with obstructive sleep apnea (OSA).Specifically, we evaluated the effects of a combination of PAP and weight-loss Mediterranean diet intervention on improving PAP adherence, Body mass index (ΒΜΙ), daytime symptoms, mainly sleepiness and arterial blood pressure measurements over the effect of standard care alone.

Detailed Description

We designed a parallel, randomized, controlled, clinical trial. Eligible participants are adult, overweight and obese men and women, diagnosed with moderate-to-severe OSA \[apnea-hypopnea index (AHI)≥15 events/h\] through an attended overnight polysomnography. Participants, after written informed consent, were blindly randomized to a standard care group (SCG, n=37) and a Mediterranean diet group (MDG, n=37). Study groups were prescribed PAP. The SCG received oral healthy lifestyle advice and counseling on physical activity and sleep habits, while the MDG was additionally subjected to a 6-month behavioral intervention aiming at weight loss and increasing adherence to the Mediterranean diet. PAP adherence (hours of device use), BMI, daytime sleepiness, evaluated by Epworth Sleepiness Scale (ESS) and arterial blood pressure measurements were evaluated pre- and post-intervention.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
74
Inclusion Criteria
  • Patients aged >18 years with newly diagnosed moderate to severe OSA [apnea-hypopnea index (AHI)≥15 events/h] through an attended overnight polysomnographyaccording to standard criteria
  • overweight and obese [BMI>25 kg/m2]
  • eligible for PAP treatment with adherence data available in the 6-months after initiation of treatment and
  • with an above-elementary school education.
Exclusion Criteria
  • refusal to participate
  • patients on PAP treatment
  • current participation in a weight loss program
  • central sleep apnea syndromes
  • obesity hypoventilation syndrome
  • restrictive ventilator syndromes
  • severe congestive heart failure
  • a history of life-threatening arrhythmias
  • severe cardiomyopathy
  • long-term oxygen therapy
  • chronic kidney disease
  • family or personal history of mental illness
  • drug or alcohol abuse
  • severe cognitive impairment
  • concurrent oncological diseases
  • pregnancy or lactatio
  • recent hospitalization for acute or chronic respiratory disease
  • history of narcolepsy or restless leg syndrome

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Mediterranean diet group (MDG)MDG interventionThe MDG was additionally subjected to a 6-month behavioral intervention aiming at weight loss and increasing adherence to the Mediterranean diet.
Primary Outcome Measures
NameTimeMethod
Difference in PAP adherence6 months

Difference pre post in PAP adherence (hours of device use)

Secondary Outcome Measures
NameTimeMethod
Difference in Body mass index6 months

Difference pre post intervention in Body mass index

Difference in Blood pressure measurements6 months

Difference in Systolic and Diastolic Blood pressure measurements pre and post intervention

Difference in daytime sleepiness6 months

Difference ipre post intervention in daytime sleepiness assessed by Epworth Sleepiness Scale score

Trial Locations

Locations (1)

University of Crete

🇬🇷

Heraklion, Crete, Greece

© Copyright 2025. All Rights Reserved by MedPath